Furthermore, when C. elegans models of Alzheimer's disease (AD) were administered AGP, the paralysis symptoms were alleviated, in line with the protective effects observed with Root265. This evidence concerns the gene ATP5MK and early-onset autosomal dominant Alzheimer disease.